Squarepoint
ERAS icon

Squarepoint’s Erasca ERAS Stock Holding History

Squarepoint’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
135,233
+40,548
+43% +$580K ﹤0.01% 2176
2026
Q1 		$1.53M Sell
94,685
-163,590
-63% -$1.93M ﹤0.01% 2410
2025
Q4 		$961K Buy
258,275
+173,574
+205% +$488K ﹤0.01% 2643
2025
Q3 		$185K Buy
+84,701
New +$135K ﹤0.01% 3971
2025
Q2 		– Sell
-112,465
Closed -$154K – 4634
2025
Q1 		$154K Buy
112,465
+62,157
+124% +$107K ﹤0.01% 4101
2024
Q4 		$126K Buy
+50,308
New +$138K ﹤0.01% 4638
2024
Q3 		– Sell
-150,826
Closed -$356K – 4251
2024
Q2 		$356K Buy
150,826
+94,829
+169% +$205K ﹤0.01% 3319
2024
Q1 		$115K Sell
55,997
-32,467
-37% -$64.9K ﹤0.01% 3771
2023
Q4 		$188K Sell
88,464
-30,492
-26% -$64.3K ﹤0.01% 3620
2023
Q3 		$234K Buy
118,956
+101,327
+575% +$260K ﹤0.01% 3322
2023
Q2 		$48.7K Sell
17,629
-491,836
-97% -$1.4M ﹤0.01% 3443
2023
Q1 		$1.53M Buy
509,465
+254,617
+100% +$926K 0.01% 1600
2022
Q4 		$1.1M Buy
+254,848
New +$1.73M ﹤0.01% 1756
2022
Q3 		– Sell
-49,734
Closed -$277K – 3109
2022
Q2 		$277K Buy
49,734
+38,252
+333% +$250K ﹤0.01% 2322
2022
Q1 		$99K Buy
+11,482
New +$133K ﹤0.01% 2602

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Squarepoint's ERAS Position: Q2 2026 in Review

Squarepoint increased its Erasca (ERAS) stake by 43% in Q2 2026, buying an estimated $580K and bringing the position to 135,233 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Squarepoint first reported a position in ERAS in Q1 2022 and has held it in 15 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Squarepoint held 135,233 shares of Erasca worth $2.48M as of Q2 2026.
  • Squarepoint bought 40,548 Erasca shares in Q2 2026, an estimated $580K.
  • Erasca made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2176 holding.
  • Squarepoint first reported a position in Erasca in Q1 2022 and has held it in 15 quarters since.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.